版本:
中国

BRIEF-Cardiome's partner SteadyMed receives favorable ruling in its USPTO Inter Partes review

April 3 Cardiome Pharma Corp:

* Cardiome's partner SteadyMed receives favorable ruling in its USPTO Inter Partes review

* Cardiome Pharma Corp says in its ruling, PTAB found all 22 claims of '393 patent were unpatentable

* Cardiome Pharma Corp says Cardiome currently expects to file for European Medicines Agency (EMA) approval of Trevyent during 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐